Remembering Old Lessons in Prostate Cancer: Avoiding Errors 'in PARPituity'

The “experts” should maintain a stringent standard regarding what merits further development and reconsider carefully and critically the available data before committing to PARP inhibition, attacks on the PI3K pathway, and vasoactive agents in prostate cancer!
Source: Cancer Network - Category: Cancer & Oncology Source Type: news